Sprout Pharmaceuticals, which on Tuesday won regulatory approval for the first pill to aid a woman’s sex drive, will be acquired by Valeant Pharmaceuticals International for about $1 billion in cash.
Tag: Sprout Pharmaceuticals
FDA to Again Consider Drug Aimed at Women’s Sexual Dysfunction
The Food and Drug Administration said that safety concerns outweighed any benefits, and, in 2013, again rejected the drug for approval.The manufacturer, Sprout Pharmaceuticals resubmitted an application for approval in February with additional safety studies.And on Thursday, an advisory committee of the FDA will again examine the risks and rewards of the drug. Their vote could influence the final FDA decision, due in August.
FDA Approval Sought for Female Sexual Disorder Drug
Flibanserin, a non-hormonal drug for the treatment of hypoactive sexual desire disorder (HSDD) in post-menopausal women, has been resubmitted for a New Drug Application, the drug’s maker, Sprout Pharmaceuticals, of Raleigh, NC, announced.